ARDT INVESTOR DEADLINE: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following the revelation of financial discrepancies [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Postiwala v. Ardent Health, Inc., and it allows purchasers of Ardent Health securities between July 18, 2024, and November 12, 2025, to seek lead plaintiff status by March 9, 2026 [1][2]. - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable and misrepresented its financial position [3]. Group 2: Allegations Against Ardent Health - Allegations include that Ardent Health's accounts receivable framework allowed for inflated reporting by utilizing a 180-day cliff for uncollectible accounts [3]. - The company reportedly did not maintain sufficient professional malpractice liability insurance and had inadequate reserves to cover increasing claims due to social inflation in the New Mexico market [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in Q3 2025 revenue and a $57.5 million cut in EBITDA guidance, leading to a nearly 34% drop in stock price [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Ardent Health securities during the class period to seek lead plaintiff status, which enables them to direct the lawsuit on behalf of all class members [5]. - Investors are not required to serve as lead plaintiff to share in any potential recovery from the lawsuit [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, being ranked 1 in securing monetary relief for investors in securities class action cases [6].